DecisionPoint Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$75.1K Buy
1,222
+1,198
+4,992% +$75.7K 0.01% 115
2026
Q2
$1.36K Buy
24
+19
+380% +$1.09K ﹤0.01% 383
2026
Q1
$304 Sell
5
-100
-95% -$5.83K ﹤0.01% 566
2025
Q4
$5.66K Buy
105
+100
+2,000% +$4.81K ﹤0.01% 238
2025
Q3
$238 Hold
5
– – ﹤0.01% 602
2025
Q2
$238 Sell
5
-500
-99% -$24.5K ﹤0.01% 586
2025
Q1
$30.8K Hold
505
– – 0.01% 104
2024
Q4
$28.6K Hold
505
– – 0.01% 104
2024
Q3
$26.1K Hold
505
– – 0.01% 110
2024
Q2
$24K Hold
505
– – 0.01% 116
2024
Q1
$22.6K Sell
505
-652
-56% -$33.2K 0.01% 115
2023
Q4
$59.4K Hold
1,157
– – 0.03% 66
2023
Q3
$67.2K Sell
1,157
-348
-23% -$21.3K 0.04% 52
2023
Q2
$96.2K Hold
1,505
– – 0.05% 40
2023
Q1
$104K Hold
1,505
– – 0.06% 36
2022
Q4
$108K Buy
+1,505
New +$113K 0.07% 33

Other funds holding BMY

DecisionPoint Financial's BMY Position: Q3 2026 in Review

DecisionPoint Financial increased its Bristol-Myers Squibb (BMY) stake by 4,992% in Q3 2026, buying an estimated $75.7K and bringing the position to 1,222 shares worth $75.1K. The position accounts for 0.01% of the portfolio, ranked #115.

DecisionPoint Financial first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $108K in Q4 2022. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • DecisionPoint Financial held 1,222 shares of Bristol-Myers Squibb worth $75.1K as of Q3 2026.
  • DecisionPoint Financial bought 1,198 Bristol-Myers Squibb shares in Q3 2026, an estimated $75.7K.
  • Bristol-Myers Squibb made up 0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #115 holding.
  • DecisionPoint Financial first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
  • DecisionPoint Financial's Bristol-Myers Squibb position peaked at $108K in Q4 2022.
  • 907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.